SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 22, 2010
ADVANCED CELL TECHNOLOGY, INC.
(Exact name of registrant as specified in its charter)
| Delaware | | 000-50295 | | 87-0656515 |
(State or other jurisdiction of incorporation) | | (Commission File Number) | | (IRS Employer Identification Number) |
| |
| 33 Locke Street, Marlborough, MA 01752 |
| (Address of principal executive offices, including zip code) |
| |
| (510) 756-1212 |
| (Registrant’s telephone number, including area code) |
| |
| |
| (Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CAR 240.13e-4(c))
ITEM 7.01 Regulation FD Disclosure.
On November 22, 2010, Advanced Cell Technology, Inc. (the “Company”) issued a press release announcing that it received FDA clearance for the first clinical trial using embryonic stem cells to treat macular degeneration. A copy of the Company’s press released is furnished herewith as Exhibit 99.1.
ITEM 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit Number | | Description of Exhibit |
| | | |
| 99.1 | | Press release of Advanced Cell Technology, Inc., dated November 22, 2010 |
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| | ADVANCED CELL TECHNOLOGY, INC. |
| | |
| | |
| | By: | /s/ William M. Caldwell, IV |
| | | William M. Caldwell, IV |
| | | Chief Executive Officer |
| Dated: November 22, 2010 | |
EXHIBIT INDEX
| Exhibit Number | | Description of Exhibit |
| | | |
| 99.1 | | Press release of Advanced Cell Technology, Inc., dated November 22, 2010 |
